Free Trial

3 Recession-Proof Stocks With Nice Dividends

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

Should You Invest $1,000 in Kimberly-Clark Right Now?

Before you consider Kimberly-Clark, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kimberly-Clark wasn't on the list.

While Kimberly-Clark currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Kimberly-Clark (KMB)
4.3727 of 5 stars
$141.01-0.4%3.57%18.68Hold$145.08
Johnson & Johnson (JNJ)
4.953 of 5 stars
$153.17-0.3%3.39%23.03Moderate Buy$170.88
Coca-Cola (KO)
4.0623 of 5 stars
$71.84+0.2%2.84%29.09Buy$75.59
PepsiCo (PEP)
4.3947 of 5 stars
$130.15-1.3%4.37%18.73Hold$160.69
Procter & Gamble (PG)
3.9068 of 5 stars
$165.49-0.1%2.55%26.35Moderate Buy$178.52
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines